CTI BioPharma Corp. CTIC
$ 9.09
0.0%
Quarterly report 2023-Q1
added 05-15-2023
CTI BioPharma Corp. Balance Sheet 2011-2024 | CTIC
Annual Balance Sheet CTI BioPharma Corp.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
18.3 M | - | -31.5 M | -21.9 M | -22.4 M | -13.2 M | -24.7 M | -71.6 M | -53.6 M | -58.3 M | -50.4 M | -44.1 M |
Long Term Debt |
47.9 M | - | 4.46 M | 4.46 M | 9.27 M | 13.6 M | 11.3 M | 19.3 M | 8.36 M | 10.2 M | - | - |
Long Term Debt Current |
781 K | 1.16 M | 2.19 M | 1.69 M | 4.81 M | 444 K | 7.95 M | 37.4 M | 9.01 M | 3.16 M | - | - |
Total Non Current Liabilities |
- | - | 1.17 M | 9.86 M | 13.8 M | 19.5 M | 15.4 M | 24.5 M | 17.5 M | 30.9 M | 18.1 M | 16.4 M |
Total Current Liabilities |
81.1 M | 66.7 M | 17 M | 18.5 M | 23.1 M | 19.3 M | 40.6 M | 72.4 M | 36.3 M | 20.1 M | 22.7 M | 17.8 M |
Total Liabilities |
144 M | 68.7 M | 18.2 M | 28.4 M | 36.9 M | 38.8 M | 56.1 M | 96.9 M | 53.8 M | 51 M | 40.8 M | 34.2 M |
Deferred Revenue |
- | - | - | - | - | 912 K | 103 K | 578 K | 826 K | 1.01 M | - | - |
Retained Earnings |
-2.52 B | -2.43 B | -2.33 B | -2.26 B | -2.22 B | -2.2 B | -2.15 B | -2.1 B | -1.98 B | -1.88 B | -1.83 B | -1.71 B |
Total Assets |
126 M | 72.4 M | 58.2 M | 46.3 M | 89.8 M | 54.9 M | 63.8 M | 144 M | 92.3 M | 93.7 M | 73.7 M | 62.2 M |
Cash and Cash Equivalents |
30.4 M | 65.4 M | 40.4 M | 31.1 M | 36.4 M | 27.2 M | 44 M | 128 M | 70.9 M | 71.6 M | 50.4 M | 47.1 M |
Book Value |
-17.6 M | 3.77 M | 40 M | 17.9 M | 52.9 M | 16.1 M | 7.76 M | 47.4 M | 38.5 M | 42.8 M | 32.9 M | 28 M |
Total Shareholders Equity |
-17.6 M | 3.77 M | 40 M | 23.7 M | 58.7 M | 21.8 M | 13.3 M | 52 M | 41.8 M | 45.2 M | 34.6 M | 28.7 M |
All numbers in USD currency
Quarterly Balance Sheet CTI BioPharma Corp.
2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 47.8 M | 47.7 M | - | - | - | - | - | - | - | 2.05 M | 3.25 M | 4.46 M | 4.46 M | 4.46 M | 4.46 M | 9.27 M | 9.27 M | 9.27 M | 9.27 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 8.36 M | 8.36 M | 8.36 M | 8.36 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
138 M | 144 M | 140 M | 140 M | 159 M | 68.7 M | 62.3 M | 15.8 M | 16.1 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 28.4 M | 28.4 M | 28.4 M | 28.4 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 56.1 M | 56.1 M | 56.1 M | 56.1 M | 96.8 M | 96.8 M | 96.8 M | 96.8 M | 52.4 M | 52.4 M | 52.4 M | 52.4 M | 37.5 M | 37.5 M | 37.5 M | 37.5 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 806 K | 915 K | 912 K | 872 K | 1.32 M | 912 K | 103 K | 103 K | 103 K | 103 K | 578 K | 578 K | 578 K | 578 K | 826 K | 826 K | 826 K | 826 K | 1.01 M | 1.01 M | 1.01 M | 1.01 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.53 B | -2.52 B | -2.5 B | -2.49 B | -2.46 B | -2.43 B | -2.39 B | -2.36 B | -2.35 B | -2.33 B | -2.33 B | -2.33 B | -2.33 B | -2.28 B | -2.28 B | -2.28 B | -2.26 B | -2.22 B | -2.22 B | -2.22 B | -2.22 B | -2.2 B | -2.2 B | -2.2 B | -2.2 B | -2.15 B | -2.15 B | -2.15 B | -2.15 B | -2.1 B | -2.1 B | -2.1 B | -2.1 B | -1.98 B | -1.98 B | -1.98 B | -1.98 B | -1.88 B | -1.88 B | -1.88 B | -1.88 B | -1.83 B | -1.83 B | -1.83 B | -1.83 B | -1.71 B | -1.71 B | -1.71 B | -1.71 B |
Total Assets |
112 M | 126 M | 123 M | 135 M | 131 M | 72.4 M | 101 M | 77.5 M | 42.8 M | 58.2 M | 58.2 M | 58.2 M | 58.2 M | 46.3 M | 46.3 M | 46.3 M | 46.3 M | 89.8 M | 89.8 M | 89.8 M | 89.8 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 63.8 M | 63.8 M | 63.8 M | 63.8 M | 144 M | 144 M | 144 M | 144 M | 92.3 M | 92.3 M | 92.3 M | 92.3 M | 93.7 M | 93.7 M | 93.7 M | 93.7 M | 73.7 M | 73.7 M | 73.7 M | 73.7 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M |
Cash and Cash Equivalents |
24.2 M | 30.4 M | 32 M | 66.1 M | 96.9 M | 65.4 M | 95.3 M | 71.9 M | 33.1 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 43.2 M | 27.2 M | 27.2 M | 27.2 M | 44 M | 44 M | 44 M | 44 M | 128 M | 128 M | 128 M | 128 M | 70.9 M | 70.9 M | 70.9 M | 70.9 M | 71.6 M | 71.6 M | 71.6 M | 71.6 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 47.1 M | 47.1 M | 47.1 M | 47.1 M |
Book Value |
-25.3 M | -17.6 M | -16.8 M | -5.27 M | -27.9 M | 3.77 M | 38.9 M | 61.7 M | 26.7 M | 40 M | 40 M | 40 M | 40 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 52.9 M | 52.9 M | 52.9 M | 52.9 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 7.76 M | 7.76 M | 7.76 M | 7.76 M | 47.4 M | 47.4 M | 47.4 M | 47.4 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 56.2 M | 56.2 M | 56.2 M | 56.2 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M |
Total Shareholders Equity |
-25.3 M | -17.6 M | -16.8 M | -5.27 M | -27.9 M | 3.77 M | 38.9 M | 61.7 M | 26.7 M | 40 M | 46.8 M | 40 M | 40 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 52 M | 52 M | 52 M | 52 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 45.2 M | 45.2 M | 45.2 M | 45.2 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M |
All numbers in USD currency